ACTR-17. EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, FINAL RESULTS OF A MULTICENTER PHASE II STUDY
| Image |  |
|---|---|
| Description | |
| Author/s |
author: David A Reardon Mark Muzi Shiliang Huang Eudocia Q Lee Andrew J Brenner Patrick Y Wen |
| Publication date | November 5, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |